Advertisement

Antidiabetic Action of Thymoquinone

Chapter

Abstract

Diabetes has become the most common metabolic disease worldwide. Hyperglycemia has a key role in the diseases associated with diabetic complications. N. sativa seeds possess antidiabetic and hypoglycemic activity. It is the thymoquinone (TQ) content of these seeds that is the main constituent associated with the antidiabetic activity of the plant. TQ is quite effective in protecting the β-cells from damage due to oxidative stress and decreases hepatic gluconeogenesis. It prevents insulin resistance, protein glycation, and diabetic nephropathy and has many other antidiabetic properties. The antioxidant, cytoprotective and immunomodulating actions of TQ and N. sativa, may be pharmacologically relevant in curing diabetes and its complications.

References

  1. Abdelmeguid NE, Fakhoury R, Kamal SM et al (2010) Effects of Nigella sativa and thymoquinone on biochemical and subcellular changes in pancreatic β-cells of streptozotocin-induced diabetic rats. J Diabetes 2:256–266CrossRefGoogle Scholar
  2. Abel-Salam BK (2012) Immunomodulatory effects of black seeds and garlic on alloxan-induced diabetes in albino rat. Allergol Immunopathol (Madr) 40:336–340CrossRefGoogle Scholar
  3. Abu Khader MM (2012) Thymoquinone: a promising antidiabetic agent. Int J Diabetes Dev Countries 32:65–68CrossRefGoogle Scholar
  4. Al Wafai RJ (2013) Nigella sativa and thymoquinone suppress cyclooxygenase-2 and oxidative stress in pancreatic tissue of streptozotocin-induced diabetic rats. Pancreas 42:841–849CrossRefGoogle Scholar
  5. Al-Enazi MM (2007) Effect of thymoquinone on malformations and oxidative stress-induced diabetic mice. Pak J Biol Sci 10:3115–3119CrossRefGoogle Scholar
  6. Alenzi F, El-Bolkiny Y-S, Salem M (2010) Protective effects of Nigella sativa oil and thymoquinone against toxicity induced by the anti-cancer drug cyclophosphamide. Br J Biomed Sci 67:20–28CrossRefGoogle Scholar
  7. Al-Hader A, Aqel M, Hasan Z (1993) Hypoglycemic effects of the volatile oil of Nigella sativa seeds. Pharm Biol 31:96–100CrossRefGoogle Scholar
  8. Alimohammadi S, Hobbenaghi R, Javanbakht J et al (2013) Protective and anti-diabetic effects of extract from Nigella sativa on blood glucose concentrations against streptozotocin (STZ)-induced diabetic in rats: an experimental study with histopathological evaluation. Diagn Pathol 15:137CrossRefGoogle Scholar
  9. Al-Trad B, Al-Batayneh K, El-Metwally S et al (2016) Nigella sativa oil and thymoquinone ameliorate albuminuria and renal extracellular matrix accumulation in the experimental diabetic rats. Eur Rev Med Pharmacol Sci 20:2680–2688PubMedGoogle Scholar
  10. Anwar S, Khan MA, Sadaf A et al (2014) A structural study on the protection of glycation of superoxide dismutase by thymoquinone. Int J Biol Macromol 69:476–481CrossRefGoogle Scholar
  11. Badr G, Mahmoud MH, Farhat K et al (2013) Maternal supplementation of diabetic mice with thymoquinone protects their offspring from abnormal obesity and diabetes by modulating their lipid profile and free radical production and restoring lymphocyte proliferation via PI3K/AKT signaling. Lipids Health Dis 12:37CrossRefGoogle Scholar
  12. Bamosa AO, Kaatabi H, Lebda FM et al (2010) Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus. Indian J Physiol Pharmacol 54:344–354PubMedGoogle Scholar
  13. Baynes JW, Watkins NG, Fisher CI et al (1989) The Amadori product on protein: structure and reactions. Prog Clin Biol Res 304:43–67PubMedGoogle Scholar
  14. Brownlee M (1995) The pathological implications of protein glycation. Clin Invest Med 18:275–281PubMedGoogle Scholar
  15. Coman C, Rugină OD, Socaciu C (2012) Plants and natural compounds with antidiabetic action. Not Bot Horti Agrobo 40:314–325CrossRefGoogle Scholar
  16. El-Mahmoudy A, Shimizu Y, Shiina T et al (2005a) Successful abrogation by thymoquinone against induction of diabetes mellitus with streptozotocin via nitric oxide inhibitory mechanism. Int Immunopharmacol 5:195–207CrossRefGoogle Scholar
  17. El-Mahmoudy A, Shimizu Y, Shiina T et al (2005b) Macrophage-derived cytokine and nitric oxide profiles in type I and type II diabetes mellitus: effect of thymoquinone. Acta Diabetol 42:23–30CrossRefGoogle Scholar
  18. Fararh K, Atoji Y, Shimizu Y et al (2002) Isulinotropic properties of Nigella sativa oil in Streptozotocin plus Nicotinamide diabetic hamster. Res Vet Sci 73:279–282CrossRefGoogle Scholar
  19. Fararh KM, Ibrahim AK, Elsonosy YA (2010) Thymoquinone enhances the activities of enzymes related to energy metabolism in peripheral leukocytes of diabetic rats. Res Vet Sci 88:400–404CrossRefGoogle Scholar
  20. Fararh KM, Shimizu Y, Shiina T et al (2005) Thymoquinone reduces hepatic glucose production in diabetic hamsters. Res Vet Sci 79:219–223CrossRefGoogle Scholar
  21. Fouad AA, Alwadani F (2015) Ameliorative effects of thymoquinone against eye lens changes in streptozotocin diabetic rats. Environ Toxicol Pharmacol 40:960–965CrossRefGoogle Scholar
  22. Hamdy NM, Taha RA (2009) Effects of Nigella sativa oil and thymoquinone on oxidative stress and neuropathy in streptozotocin-induced diabetic rats. Pharmacology 84:127–134CrossRefGoogle Scholar
  23. Hassanien MF, Assiri AM, Alzohairy AM et al (2015) Health-promoting value and food applications of black cumin essential oil: an overview. J Food Sci Technol 52:6136–6142CrossRefGoogle Scholar
  24. Hawsawi ZA, Ali BA, Bamosa AO (2001) Effect of Nigella sativa (black seed) and thymoquinone on blood glucose in albino rats. Ann Saudi Med 21:242–244CrossRefGoogle Scholar
  25. Kaleem M, Kirmani D, Asif M et al (2006) Biochemical effects of Nigella sativa L seeds in diabetic rats. Indian J Exp Biol 44:745–748PubMedGoogle Scholar
  26. Kanter M (2008) Effects of Nigella sativa and its major constituent, thymoquinone on sciatic nerves in experimental diabetic neuropathy. Neurochem Res 33:87–96CrossRefGoogle Scholar
  27. Kanter M (2009) Protective effects of thymoquinone on streptozotocin-induced diabetic nephropathy. J Mol Histol 40:107–115CrossRefGoogle Scholar
  28. Kanter M, Akpolat M, Aktas C (2009) Protective effects of the volatile oil of Nigella sativa seeds on β-cell damage in streptozotocin-induced diabetic rats: a light and electron microscopic study. J Molecular Histol 40:379–385CrossRefGoogle Scholar
  29. Kanter M, Coskun O, Korkmaz A et al (2004) Effects of Nigella sativa on oxidative stress and β-cell damage in streptozotocin-induced diabetic rats. Anat Rec A Discov Mol Cell Evol Biol 279:685–691CrossRefGoogle Scholar
  30. Khan MA, Anwar S, Aljarbou AN et al (2014) Protective effect of thymoquinone on glucose or methylglyoxal-induced glycation of superoxide dismutase. Int J Biol Macromol 65:16–20CrossRefGoogle Scholar
  31. Kitabchi AE, Umpierrez GE, Miles JM et al (2009) Hyperglycemic crises in adult patients with diabetes. Diabetes Care 32:1335–1343CrossRefGoogle Scholar
  32. Liu H, Liu HY, Jiang YN et al (2016) Protective effect of thymoquinone improves cardiovascular function, and attenuates oxidative stress, inflammation and apoptosis by mediating the PI3K/Akt pathway in diabetic rats. Mol Med Rep 13:2836–2842CrossRefGoogle Scholar
  33. Losso JN, Bawadi HA, Chintalapati M (2011) Inhibition of the formation of advanced glycation end products by thymoquinone. Food Chem 128:55–61CrossRefGoogle Scholar
  34. Marles RJ, Farnsworth NR (1995) Antidiabetic plants and their active constituents. Phytomedicine 2:137–189CrossRefGoogle Scholar
  35. Neglia CI, Cohen HJ, Garber AR et al (1983) NMR investigation of nonenzymatic glucosylation of protein. Model studies using RNase A. J Biol Chem 258:14279–14283PubMedGoogle Scholar
  36. Pari L, Sankaranarayanan C (2009) Beneficial effects of thymoquinone on hepatic key enzymes in streptozotocin–nicotinamide induced diabetic rats. Life Sci 85:830–834CrossRefGoogle Scholar
  37. Pei X, Li X, Chen H et al (2016) Thymoquinone inhibits angiotensin II-induced proliferation and migration of vascular smooth muscle cells through the AMPK/PPARγ/PGC-1α pathway. DNA Cell Biol 35:426–433CrossRefGoogle Scholar
  38. Prabhakar P, Reeta KH, Maulik SK et al (2015) Protective effect of thymoquinone against high-fructose diet-induced metabolic syndrome in rats. Eur J Nutr 54:1117–1127CrossRefGoogle Scholar
  39. Rchid H, Chevassus H, Nmila R et al (2004) Nigella sativa seed extracts enhance glucose-induced insulin release from rat-isolated Langerhans islets. Fundam Clin Pharmacol 18:525–529CrossRefGoogle Scholar
  40. Riddle MC (2005) Glycemic management of type 2 diabetes: an emerging strategy with oral agents, insulins, and combinations. Endocrinol Metab Clin N Am 34:77–98CrossRefGoogle Scholar
  41. Salama RH (2011) Hypoglycemic effect of lipoic acid, carnitine and Nigella sativa in diabetic rat model. Int J Health Sci 5:126–134Google Scholar
  42. Sangi SMA, Sulaiman MI, Abd El-wahab MF et al (2015) Antihyperglycemic effect of thymoquinone and oleuropein, on streptozotocin-induced diabetes mellitus in experimental animals. Pharmacogn Mag 11:S251–S257CrossRefGoogle Scholar
  43. Sankaranarayanan C, Pari L (2011) Thymoquinone ameliorates chemical induced oxidative stress and β-cell damage in experimental hyperglycemic rats. Chem Biol Interact 190(2–3):148–154CrossRefGoogle Scholar
  44. Sayed AA (2012) Thymoquinone and proanthocyanidin attenuation of diabetic nephropathy in rats. Eur Rev Med Pharmacol Sci 16:808–815PubMedGoogle Scholar
  45. Sayed AA, Morcos M (2007) Thymoquinone decreases AGE-induced NF-kappaB activation in proximal tubular epithelial cells. Phytother Res 21:898–899CrossRefGoogle Scholar
  46. Seven A, Guzel S, Seymen O et al (2003) Nitric oxide synthase inhibition by L-NAME in streptozotocin-induced diabetic rats: impacts on oxidative stress. Tohoku J Exp Med 99:205–210CrossRefGoogle Scholar
  47. Shabana A, El-Menyar A, Asim M et al (2013) Cardiovascular benefits of black cumin (Nigella sativa). Cardiovascular Toxicol 13:9–21CrossRefGoogle Scholar
  48. Shafiq H, Ahmad A, Masud T et al (2014) Cardio-protective and anti-cancer therapeutic potential of Nigella sativa. Iran J Basic Med Sci 17:967–979PubMedPubMedCentralGoogle Scholar
  49. Sobhi W, Stevigny C, Duez P et al (2016) Effect of lipid extracts of Nigella sativa L. seeds on the liver ATP reduction and alpha-glucosidase inhibition. Pak J Pharm Sci 29:111–117PubMedGoogle Scholar
  50. Soumyanath A (2006) Traditional medicines in modern times-anti-diabetic plants. CRC Press, Boca Raton/London/New YorkGoogle Scholar
  51. Stadler K (2012) Oxidative stress in diabetes. Adv Exp Med Biol 771:272–287PubMedGoogle Scholar
  52. Sultan MT, Butt MS, Karim R et al (2014) Effect of Nigella sativa fixed and essential oils on antioxidant status, hepatic enzymes, and immunity in streptozotocin induced diabetes, mellitus. BMC Complement Altern Med 14:193CrossRefGoogle Scholar
  53. Thornalley PJ, Langborg A, Minhas HS (1999) Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 344:109–116CrossRefGoogle Scholar
  54. Younus H, Anwar S (2016) Prevention of non-enzymatic glycosylation (glycation): implication in the treatment of diabetic complication. Int J Health Sci 10:261–277Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  1. 1.Interdisciplinary Biotechnology UnitAligarh Muslim UniversityAligarhIndia

Personalised recommendations